BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36848481)

  • 1. The effect of miR-372-5p regulation on CDX1 and CDX2 in the gastric cancer cell line.
    Gharakhyli EA; Tabar Molla Hassan A; Alipour M; Vahidi S; Samadani AA
    Horm Mol Biol Clin Investig; 2023 Sep; 44(3):271-276. PubMed ID: 36848481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells.
    Kiani S; Akhavan-Niaki H; Fattahi S; Kavoosian S; Babaian Jelodar N; Bagheri N; Najafi Zarrini H
    Gene; 2018 Dec; 678():115-123. PubMed ID: 30096452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1.
    Li T; Lu YY; Zhao XD; Guo HQ; Liu CH; Li H; Zhou L; Han YN; Wu KC; Nie YZ; Shi YQ; Fan DM
    Oncogene; 2014 Feb; 33(6):783-93. PubMed ID: 23353818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-9 downregulates CDX2 expression in gastric cancer cells.
    Rotkrua P; Akiyama Y; Hashimoto Y; Otsubo T; Yuasa Y
    Int J Cancer; 2011 Dec; 129(11):2611-20. PubMed ID: 21225631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
    World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
    Li T; Guo H; Li H; Jiang Y; Zhuang K; Lei C; Wu J; Zhou H; Zhu R; Zhao X; Lu Y; Shi C; Nie Y; Wu K; Yuan Z; Fan DM; Shi Y
    Gut; 2019 Oct; 68(10):1751-1763. PubMed ID: 30635407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation.
    Nakayama C; Yamamichi N; Tomida S; Takahashi Y; Kageyama-Yahara N; Sakurai K; Takeuchi C; Inada KI; Shiogama K; Nagae G; Ono S; Tsuji Y; Niimi K; Fujishiro M; Aburatani H; Tsutsumi Y; Koike K
    Cancer Sci; 2018 Dec; 109(12):3853-3864. PubMed ID: 30289576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic Cdx2 induces endogenous Cdx1 in intestinal metaplasia of Cdx2-transgenic mouse stomach.
    Mutoh H; Hayakawa H; Sakamoto H; Sashikawa M; Sugano K
    FEBS J; 2009 Oct; 276(20):5821-31. PubMed ID: 19725873
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yu J; Zhang X; Ma Y; Li Z; Tao R; Chen W; Xiong S; Han X
    Cancer Biother Radiopharm; 2021 Feb; 36(1):95-105. PubMed ID: 32552008
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells.
    Tagawa T; Haraguchi T; Hiramatsu H; Kobayashi K; Sakurai K; Inada K; Iba H
    Biochem J; 2012 Nov; 447(3):449-55. PubMed ID: 22849325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p.
    Jiang Y; Zhang Y; Li F; Du X; Zhang J
    Tumour Biol; 2016 Jan; 37(1):1041-9. PubMed ID: 26269116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice.
    Mutoh H; Sakurai S; Satoh K; Osawa H; Hakamata Y; Takeuchi T; Sugano K
    Gut; 2004 Oct; 53(10):1416-23. PubMed ID: 15361487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-155-5p promotes proliferation and migration of gastric cancer cells by inhibiting TP53INP1 expression.
    Shi SS; Zhang HP; Yang CQ; Li LN; Shen Y; Zhang YQ
    Pathol Res Pract; 2020 Jun; 216(6):152986. PubMed ID: 32527448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
    Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
    J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells.
    Mallo GV; Soubeyran P; Lissitzky JC; André F; Farnarier C; Marvaldi J; Dagorn JC; Iovanna JL
    J Biol Chem; 1998 May; 273(22):14030-6. PubMed ID: 9593754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
    Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
    J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-371-5p targets SOX2 in gastric cancer.
    Li YJ; Dong M; Kong FM; Zhou JP; Liang D; Xue HZ
    Oncotarget; 2016 May; 7(22):31993-2005. PubMed ID: 27015119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
    Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
    World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma.
    Samadani AA; Nikbakhsh N; Taheri H; Shafaee S; Fattahi S; Pilehchian Langroudi M; Hajian K; Akhavan-Niaki H
    Pathol Oncol Res; 2019 Jul; 25(3):1215-1222. PubMed ID: 30685841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hsa_circ_0000670 promoted the progression of gastric cancer through the miR-515-5p/SIX1 molecular axis].
    Gu H; Ruan RJ; Lu XD; Chu XF
    Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):238-252. PubMed ID: 36944545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.